Taro-candesartan: Affected Lots Were Manufactured Using An Active Ingredient That Was Out Of Specification For Dissolution
Certain batches of TARO-CANDESARTAN tablets have been recalled in Canada because the active ingredient in these batches doesn't meet the required dissolution specifications, meaning it may not break down properly in the body. This is a Class I recall, which indicates a serious quality issue. The affected product was distributed across Canada.
- Product
- TARO-CANDESARTAN
- Reason
- Product quality concern
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-02-09
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/daa00c77-4acd-4a26-90bd-5f01fd44d57b